Mitchell Glass

О себе

Mitchell Glass, M.D., is a physician-executive and biotech operator who became President and Chief Medical Officer of MyMD Pharmaceuticals in June 2024; the company is now TNF Pharmaceuticals. Public company and company biographies describe him as a founder and principal of Medpro Investors, a healthcare-focused venture capital firm, alongside a long career in drug development, regulatory strategy, and company building. His prior public roles include executive positions at Invion, AQUMEN, AtheroGenics, SmithKline Beecham, and leadership work with the Science Center.

Области интересов